Current Residents
Savitaa Dookran, PharmD
PGY2 Oncology Pharmacy Resident
Email: sldookran@houstonmethodist.org
Savitaa was born and raised in San Antonio, Texas. She earned her Bachelor of Science degree in Biomedical Sciences from Texas A&M University-Corpus Christi before obtaining her Doctor of Pharmacy degree from the University of Houston College of Pharmacy in 2025. She completed her PGY1 residency at Houston Methodist Sugar Land Hospital and is currently pursuing a PGY2 residency in oncology, her professional area of interest. Outside of pharmacy, Savitaa enjoys traveling, watching true crime documentaries, and playing tennis.
Major research project: Early Immune Priming Window: Association Between Time-of-Day of Initial Immune Checkpoint Inhibitor Infusions and Outcomes in Advanced Melanoma
Quality improvement project: Implementation of DPYD Screening for Fluoropyrimidine-Based Therapy
Continuing education program: ctDNA Monitoring in Oncology: Earlier Detection, Better Outcomes, or a Path to Overtreatment?
PGY2 Oncology Pharmacy Resident
Email: xpham@houstonmethodist.org
Xay was born and raised in Vietnam. She completed her undergraduate studies at the University of Texas at El Paso and earned her Doctor of Pharmacy degree from the University of California, San Francisco in 2024. She completed her PGY1 Pharmacy Residency at Houston Methodist in Houston, TX. In her free time, she enjoys traveling, exploring new coffee shops and restaurants, and watching K-dramas.
Major research project: Impact of TOPAZ-1 regimen dose modifications on survival outcomes in patients with advanced biliary tract cancers
Quality improvement project: TCE Therapy Administration in the Outpatient Setting with Integrated CAR-T/TCE Toxicity Management
Continuing education program: The Proof is in the Plasma: ctDNA Monitoring Beyond the Hype